Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
July 11th, 2018 |
Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional) |
National Institutes of Health |
March 19th, 2019 |
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) |
National Institutes of Health |
July 25th, 2019 |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
July 25th, 2019 |
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2021 |
Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2021 |
Mentored Research Scientist Development Award (Parent K01 - Clinical Trial Required) |
National Institutes of Health |
February 13th, 2019 |
Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2021 |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
National Institutes of Health |
September 28th, 2018 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 28th, 2018 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
March 19th, 2019 |
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) |
National Institutes of Health |
February 24th, 2020 |
National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional) |
National Institutes of Health |
March 30th, 2019 |
Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) |
National Institutes of Health |
March 29th, 2019 |
Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional) |
National Institutes of Health |
March 29th, 2019 |
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
National Institutes of Health |
November 1st, 2019 |
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required) |
National Institutes of Health |
November 1st, 2019 |
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required) |
National Institutes of Health |
February 28th, 2019 |
Ancillary Studies to Identify Behavioral and/or Psychological Phenotypes Contributing to Obesity (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) |
National Institutes of Health |
March 13th, 2018 |
Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01 Clinical Trial Optional) |
National Institutes of Health |
|
March 14th, 2018 |
The Role of the Microbiome in the Developmental Origins of Health and Disease (DOHaD) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 13th, 2019 |
Tobacco Regulatory Science (R21 Clinical Trial Optional) |
National Institutes of Health |
February 13th, 2019 |
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
National Institutes of Health |
September 28th, 2018 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 28th, 2018 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2021 |
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) |
National Institutes of Health |
November 12th, 2018 |
Capacity Building Assistance (CBA) for High Impact HIV Prevention Program Integration |
Centers for Disease Control NCHHSTP |
January 16th, 2018 |
Opioid State Targeted Response (STR) Supplement (Short Title: STR Supplement) |
Substance Abuse and Mental Health Services Adminis |
January 19th, 2018 |
Limited Competition: RCMI Research Coordination Network (RRCN) (U54) |
National Institutes of Health |
January 7th, 2021 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) |
National Institutes of Health |
January 7th, 2020 |
Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2019 |
Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R34 Clinical Trial Required) |
National Institutes of Health |
September 7th, 2019 |
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2019 |
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2021 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) |
National Institutes of Health |
March 23rd, 2018 |
Mechanistic Basis of Diffuse White Matter Disease and Small Vessel Pathology in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01) |
National Institutes of Health |
March 30th, 2018 |
Shedding light on the dark genome: Long Non-coding RNA in Cardiovascular, Lung, Blood, and Sleep Research (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2018 |
Pilot Services Research Grants Not Involving Interventions (R34 Clinical Trial Optional) |
National Institutes of Health |